Sumitomo Pharma Co Ltd ESG Meeting Transcript
My name is Naoki Noguchi. Thank you all very much for taking the time out of your busy schedules to join us today.
Let me start with the agenda of today's meeting. Here is the table of contents. We are currently reorganizing our material issues in terms of their impact on the value we provide in accordance with our corporate mission. We would like to hear your honest opinion about our capital, in other words, strength and potential, which we consider important for rearranging the material issues and are the source of our unique value creation.
First, I would like to offer a presentation for about 15 minutes or shorter, and then we will move on to the panel discussion. Sumitomo Pharma is in the process of preparing a material issue and would like to bring our assessment to a higher-quality level. At this stage, we would like to receive candid feedback from the investors and analysts and exchange ideas.
When we first identified material issues back in FY 2018, we categorized these issues in 2
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
